arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Simran Shetty

2 papers · 2023–2023

2023: 2
2023peak 2 in 20232023

Frequent co-authors

Papers

showing 1–2 of 2 RSS

Exploring SureChEMBL from a drug discovery perspective

Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius +2 more

Computational Theory and Mathematics · bioRxiv (Cold Spring Harbor Laboratory) · · cited 9× · DOI ↗ · more like this ·

Abstract In the pharmaceutical industry, the patent protection of drugs and medicines is accorded importance because of the high costs involved in the development of novel drugs. Over the years, researchers have analyzed patent documents to identify freedom-to-operate spaces for novel drug candidates. To assist this, several well established public patent document data repositories have enabled automated methodologies for extracting information on therapeutic agents. In this study, we delve into one such publicly available patent database, SureChEMBL, which catalogues patent documents related to life sciences. Our exploration begins by identifying patent compounds across public chemical data resources, followed by pinpointing sections in patent documents where the chemical annotations were found. Next, we exhibit the potential of compounds to serve as drug candidates by evaluating their…

Medicinal chemistry lens on patent data in SureChEMBL

Yojana Gadiya, Simran Shetty, Martin Hofmann‐Apitius +2 more

Computational Theory and Mathematics · Research Square · · cited 0× · DOI ↗ · more like this ·

Abstract In the pharmaceutical industry, the patent protection of drugs and medicines is accorded particular importance because of the high costs of research and development (R&D), associated with the considerable risks inherent in the creation of novel drugs. Consequently, patents play a pivotal role in ensuring a suitable return on R&D investments, especially those directed toward clinical trials. The patent corpus has been analyzed by researchers to identify freedom-to-operate spaces for novel drug candidates. Several well-established public patent data repositories have enabled automated methodologies for extracting information on therapeutic agents. In this manuscript, we delve into one such publicly available patent database, SureChEMBL, which catalogues patents related to life sciences. Our exploration begins by evaluating the coverage of compounds within SureChEMBL in…